Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Oncology
Oncolog, Volume 58, Number 10, October 2013, Bryan Tutt, Sunni Hosemann, C. Wilcox
Oncolog, Volume 58, Number 10, October 2013, Bryan Tutt, Sunni Hosemann, C. Wilcox
OncoLog MD Anderson's Report to Physicians (All issues)
- Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer May replace Axillary Dissection for Some Patients: Sentinel lymph node dissection has become a standard staging tool for breast cancer patients with no clinical eveidence of disease in the lymph nodes
- INBRIEF: miR-200 MicroRNAs Slow Tumor Growth
- Compass: Resectable or Borderline Resectable Pancreatic Adenocarcinoma: Initial Treatment Options-Neoadjuvent chemoradiation may benefit patients with resectable disease
- HOUSE CALL: Hereditary Cancers: Genetic screening can give valuable information
Oncolog, Volume 58, Number 04, April 2013, Kathryn L. Hale, Sunni Hosemann
Oncolog, Volume 58, Number 04, April 2013, Kathryn L. Hale, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Preventing and Treating Graft-Versus-Host Disease After Stem Cell Transplantation: Each year, thousands of patients with hematologic malignancies undergo allogeneic (donor) stem cell transplantation (SCT), which offers a chance at cure. Graft-versus-host disease (GHVD) is a potentially deadly complication of this therapy and occurs in 25%-60% of patients. However, clinicians and researchers are continually working to reduce the rate of GVHD occurrance and improve patient outcomes
- Compass: Breast cancer Risk Reduction: Women at increased risk have multiple options
- HOUSE CALL: Benefits of In-Person Support Groups- Face-to-face contact helps people cope with chronic illness